Latest Breaking News On - போஹெரிங்கர் இஂகல்‌ஹைம் கனடா லிமிடெட் - Page 1 : comparemela.com

Boehringer Ingelheim Canada supports PF Awareness Month with Life with PF campaign

Boehringer Ingelheim Canada supports PF Awareness Month with Life with PF campaign
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAnne coffeySharon leeAndrea sambatiBoehringer ingelheim canada ltdBritish lung foundationBrand communicationsAnimal healthBoehringer ingelheimAmerican lung associationCanadian pulmonary fibrosis foundationExecutive directorCanadian pulmonary fibrosisHuman pharmaBiopharmaceutical contract

National health pilot project works to combat diabetes in four First Nations communities

National health pilot project works to combat diabetes in four First Nations communities
theturtleislandnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theturtleislandnews.com Daily Mail and Mail on Sunday newspapers.

United statesFrances chartrandNorman bernardLynda powlessJudith sayersAndrea sambatiBoehringer ingelheim canada ltdFederation of manitobaResearch manitobaTribal councilIndigenous health collaborationsIsadore dayOntario regiona chief isadore dayNation buildingFirst nationsHealth collaborations

Lung disease specialist takes up chair named for mentor

Lung disease specialist takes up chair named for mentor Will continue his ground-breaking research in Interstitial Lung Disease (ILD) 18-May-2021 10:15 AM EDT, by McMaster University McMaster University Martin Kolb is research director at the Firestone Institute for Respiratory Health at McMaster and St. Joseph’s Healthcare Hamilton, as well as division director for respirology at the Department of Medicine. Newswise Hamilton, ON (May 18, 2021) – People with incurable lung diseases have a powerful champion in McMaster University’s Martin Kolb. Kolb begins his five-year appointment as the inaugural Jack Gauldie Boehringer Ingelheim Chair in Interstitial Lung Disease (ILD) on July 1, and he will continue his ground-breaking research into this group of incurable and often-lethal respiratory illnesses.

Paul obyrneGabriel kimJack gauldie boehringer ingelheimJack gauldieBoehringer ingelheim canada ltdMcmaster immunology research centreMcmaster distinguished university professorFaculty of health sciencesBoehringer ingelheimMcmaster university martin kolbFirestone institute for respiratory health at mcmasterDepartment for pathologyJulius maximillian universityDepartment of medicineMcmaster department of medicineMcmaster university